Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney Disease

NCT05593575 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: SPH3127+SPH3127matching placebo+valsartan matching placebo
DRUG: SPH3127+SPH3127matching placebo+valsartan matching placebo
DRUG: SPH3127+valsartan matching placebo
DRUG: SPH3127 matching placebo+valsartan

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd